Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF.
about
Pretargeted radioimmunotherapy for hematologic and other malignanciesTumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.Adding a clearing agent to pretargeting does not lower the tumor accumulation of the effector as predicted.Human islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant modelCancer radioimmunotherapy.Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibodyAn experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effectorReplacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation.A semiempirical model of tumor pretargeting.The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size.A preliminary study on the expression of tumor-associated glycoprotein-72 in human gliomas.Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies.
P2860
Q34113941-BE9DE1A8-1307-485B-9F5A-D67BE5BA13D7Q34126851-A0F11620-E33F-4F1C-A516-0D704DDE5703Q34519414-AD4A0A2D-440C-42A0-B11D-E2D607F75924Q35028182-F5690C95-ADCD-4C48-BBDE-9171ECA632FFQ35070045-78FB2C2E-F299-45EB-8BEF-2990906620F0Q35991899-02D61A65-03C0-441B-9459-FF6EA20FBAD2Q37154201-A35DB819-52AC-4007-9490-546B849578EDQ37288100-03D929CC-4BD6-4BA4-8698-DEA092B77665Q37288717-46AE3290-1CBD-4EBC-8511-CC1B728F8C45Q37481714-A98C3564-7F59-4B48-A10A-FE9025340F3AQ49016454-D8DB12F5-C51A-4CB9-A585-5886A6C95C38Q55709954-6942E03B-4FEA-4483-B53E-ECEA6E004CDB
P2860
Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pretargeting CWR22 prostate tu ...... tibody and radiolabeled cMORF.
@en
type
label
Pretargeting CWR22 prostate tu ...... tibody and radiolabeled cMORF.
@en
prefLabel
Pretargeting CWR22 prostate tu ...... tibody and radiolabeled cMORF.
@en
P2093
P2860
P1476
Pretargeting CWR22 prostate tu ...... tibody and radiolabeled cMORF.
@en
P2093
Donald J Hnatowich
Guozheng Liu
Mary Rusckowski
P Hendrik Pretorius
Shuping Dou
Xinrong Liu
P2860
P2888
P304
P356
10.1007/S00259-007-0606-Z
P577
2007-10-02T00:00:00Z